(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone,
AT 13387,
AT-13387,
AT13387,
onalespib,
Onalespib,
AT13387,
912999-49-6,
AT-13387,
AT 13387,
UNII-Q7Y33N57ZZ,
(2,4-Dihydroxy-5-isopropylphenyl)(5-((4-methylpiperazin-1-yl)methyl)isoindolin-2-yl)methanone,
Onalespib (AT13387),
Q7Y33N57ZZ,
ATI-13387X,
(2,4-Dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone,
C24H31N3O3,
(2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone;(2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone,
4-({5-[(4-methylpiperazin-1-yl)methyl]-2,3-dihydro-1H-isoindol-2-yl}carbonyl)-6-(propan-2-yl)benzene-1,3-diol,
Onalespib [USAN:INN],
onalespibum,
Onalespib (USAN/INN),
MLS006011085,
SCHEMBL382780,
CHEMBL1214827,
DTXSID80238485,
CHEBI:140592,
IFRGXKKQHBVPCQ-UHFFFAOYSA-N,
HMS3654O12,
BCP03601,
EX-A1798,
2232AH,
BDBM50005782,
s1163,
ZINC43208226,
AKOS027338622,
BCP9000333,
CS-0969,
SB16645,
NCGC00346674-01,
NCGC00346674-05,
4CA-0194,
AK340878,
BC261900,
HY-14463,
Methanone, (1,3-dihydro-5-((4-methyl-1-piperazinyl)methyl)-2H-isoindol-2-yl)(2,4-dihydroxy-5-(1-methylethyl)phenyl)-,
SMR004702873,
BCP0726000186,
SW218138-2,
D10719,
W-5763,
Onalespib pound AT13387 ATI13387X pound(c),
AT-13387;AT13387;AT 13387;912999-49-6,
(2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(4-methyl-piperazin-1-ylmethyl)-1,3-dihydro-isoindol-2-yl]-methanone,
(2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(4-methyl-piperazin-1-ylmethyl)-1,3-dihydro-isoindol-2-yl]methanone,
(2,4-dihydroxy-5-isopropylphenyl){5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydro-2H-isoindol-2-yl}methanone,
[2,4-dihydroxy-5-(propan-2-yl)phenyl]{5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydro-2H-isoindol-2-yl}methanone,
D06YSP,
CID11955716,
CID 11955716,
A4056,
A11062,
C552103,